2024 San Antonio Breast Cancer Symposium

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

2024 San Antonio Breast Cancer Symposium

Dec 18, 2024, 13:14 | Insight

Francisco J. Esteva: Exploring the latest advancements in breast cancer research and treatment

Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…

Dec 15, 2024, 08:59 | Blog

Francisco J. Esteva: The role of immunotherapy in early-stage triple-negative breast cancer

Francisco J. Esteva, Professor of Medicine at Zucker School of Medicine and Chief of Division…

Dec 12, 2024, 20:59 | Blog

Francisco Esteva: De-escalating neoadjuvant chemotherapy in HER2+ breast cancer

Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital,…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023